| Analysis | Metabolite Name | Measured Value | Units | Cell Type:HAHA | Stimulation |
|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 21624 | Peak area | IFN-G |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 79687 | Peak area | Untreated |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 149158 | Peak area | Untreated |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | Peak area | IFN-G | |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | Peak area | IL-17A | |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | Peak area | TNF-alpha | |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | Peak area | TNF-alpha+IL-17A | |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | Peak area | IL-17A | |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | Peak area | TNF-alpha | |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | Peak area | TNF-alpha+IL-17A | |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | Peak area | IFN-G | |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | Peak area | IL-17A | |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | Peak area | TNF-alpha | |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | Peak area | TNF-alpha+IL-17A | |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | Peak area | Untreated |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|